Aclarion Inc. (ACON)
NASDAQ: ACON
· Real-Time Price · USD
6.80
0.01 (0.15%)
At close: May 02, 2025, 3:59 PM
6.80
0.00%
After-hours: May 02, 2025, 04:06 PM EDT
0.15% (1D)
| Bid | 6.52 |
| Market Cap | 3.96M |
| Revenue (ttm) | 45.72K |
| Net Income (ttm) | -6.99M |
| EPS (ttm) | -5151.64 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 7.24 |
| Volume | 41,845 |
| Avg. Volume (20D) | 217,032 |
| Open | 6.79 |
| Previous Close | 6.79 |
| Day's Range | 6.51 - 7.21 |
| 52-Week Range | 6.20 - 3500.41 |
| Beta | 1.08 |
About ACON
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclari...
Sector Healthcare
IPO Date Apr 22, 2022
Employees 5
Stock Exchange NASDAQ
Ticker Symbol ACON
Website https://www.aclarion.com
Analyst Forecast
According to 2 analyst ratings, the average rating for ACON stock is "Hold." The 12-month stock price forecast is $481, which is an increase of 6973.53% from the latest price.
Stock ForecastsNext Earnings Release
Aclarion Inc. is scheduled to release its earnings on May 14, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+11.49%
Aclarion shares are trading higher after the compa...
Unlock content with
Pro Subscription
1 month ago
-23.05%
Aclarion shares are trading lower after the company announced a 1-for-27 reverese stock split.
2 months ago · prismmediawire.com
Aclarion Announces CLARITY Trial for Nociscan Now Fully FundedBroomfield, CO, February 4, 2025 – PRISM MediaWire – Aclarion, Inc.